CLDX vs MSFT: Which Stock is Better?

Side-by-side comparison of Celldex Therapeutics Inc and Microsoft Corporation in 2026

Comparison Updated:

CLDX

Celldex Therapeutics Inc

$39.24

MSFT

Microsoft Corporation

$499.32

Key Metrics Comparison

MetricCLDXMSFTWinner
Market Cap$2.35B$3.71TMSFT
P/E RatioN/A33.89CLDX
EPS (TTM)$N/A$14.08MSFT
Revenue Growth-70.8%18.4%MSFT
Gross Margin0.0%67.9%MSFT

Analyze CLDX

Full quant analysis

Analyze MSFT

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CLDX or MSFT a better investment?

Comparing CLDX and MSFT: Celldex Therapeutics Inc has a market cap of $2.35B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CLDX and MSFT?

CLDX (Celldex Therapeutics Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CLDX or MSFT?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CLDX or MSFT?

MSFT has higher revenue growth at 18.4% vs -70.8% for CLDX.

Which company is more profitable: CLDX or MSFT?

Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for CLDX.

Which is the larger company: CLDX or MSFT?

Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $2.35B for CLDX.

Should I buy CLDX or MSFT in 2026?

Both CLDX and MSFT have investment merit. CLDX trades at $39.24 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CLDX and MSFT stock?

Key differences: Market Cap ($2.35B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (-70.8% vs 18.4%), Gross Margin (0.0% vs 67.9%).

Should I buy CLDX or MSFT in 2026?

The choice between CLDX and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.

What is the market cap comparison between CLDX and MSFT?

CLDX (Celldex Therapeutics Inc) has a market cap of $2.35B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.

Popular Stock Comparisons